News

The Business Journals18y
'Important to move forward but not lose the past'
The process that rebranded Albany Molecular Research Inc. as "AMRI" began about a year ago with a transtional logo. The 16-year-old Albany-based drug-discovery company had just purchased a company ...
FiercePharma3y
Behind the rebrand: AMRI swaps acronym legacy name for Curia to set stage for future growth
From Albany to ancient Rome, AMRI’s swap of its legacy location name to the stylized industry-relevant Curia was just six months in the making. VSA Partners, a brand strategy and design agency ...
Business Insider8y
WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders
NEW YORK, June 9, 2017 /PRNewswire/ -- The proposed acquisition of Albany Molecular Research Inc. ("AMRI" or the "Company") (NASDAQ: AMRI) by affiliates Carlyle Group LP and GTCR LLC (the ...
The Business Journals11y
AMRI's new CEO looking to buy competitors
William Marth, president and CEO of Albany Molecular Research Inc. Marth assumed those roles at the start of 2014, succeeding co-founder Tom D'Ambra (who is now AMRI's chairman). AMRI; Albany ...
Business Wire4y
ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the ...
WESTPORT, Conn.--(BUSINESS WIRE)--ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc., (AMRI), a leading global contract ...
Times Union8y
Albany Molecular bought by private firms for $922M
Albany Molecular — which did not embrace the AMRI moniker until 2007 — got its first big break in 1995, when it teamed up with a Swedish research company for a cardiovascular drug.
MarketWatch8y
Albany Molecular Research to be taken private for $21.75 a share in cash
Albany Molecular Research Inc. said Tuesday it has ... The deal has been approved by AMRI's board and must now be approved by shareholders. The deal will be financed with a mixture of debt and ...
Times Union1y
Albany Molecular's $922 million deal was more than a year in the making
The sale of Albany Molecular Research Inc. in a $922 million ... Advertisement Article continues below this ad At the time, AMRI's shares were trading for roughly $14.50. Fifteen months later ...
Business Wire4y
Albany Molecular Research Inc. (AMRI) to Present at Jefferies 2020 Virtual London Healthcare Conference
ALBANY, N.Y.--(BUSINESS WIRE)--Albany Molecular Research, Inc., (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that its ...
Business Insider8y
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash
ALBANY, N.Y., June 6, 2017 /PRNewswire/ -- Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences ...
Nasdaq4y
ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the ...
About AMRI AMRI, a contract research development and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life.